]>
IRCT20180114038369N1 IRCT 2018-03-18 Ghoum University of Medical Sciences Comparison between the effect of Rosuvastatin and Orlept (Sodium Valproate) in Decrease of migraine headaches Comparison between the effect of Rosuvastatin and Orlept (Sodium Valproate) in Decrease of migraine headaches 2018-01-30 anticipated 40 Complete https://irct.ir/trial/28937 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will also be done using the permutated block randomization method, Blinding description: To blind this study, each patient given a special code. Prescribing medicines in a double-blind manner, the medications are given to the patients by the supervisor of the hospital, in accordance with the codes prescribed in the package. N/A Migraine headaches. Intervention 1: Intervention group: Treatment in Group 1 using sodium valproate. Intervention 2: Intervention group: Treatment in group two using rosuvastatin tablets. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is limited time
public Reyhaneh Tabaraei
Saheli Ave.
Qom Iran (Islamic Republic of) 3716987366 +98 25 3107 1300 rtabaraii@muq.ac.ir Ghoum University of Medical Sciences scientific Reyhaneh Tabaraei
Saheli Ave.
Qom Iran (Islamic Republic of) 3716987366 +98 25 3107 1300 rtabaraii@muq.ac.ir Ghoum University of Medical Sciences Iran (Islamic Republic of) Those who have not received sodium valproate within the last six month. Have migraine headaches With or Without a up to 6 month before this study Confirmation of the presence of migraine by the neurologist There are more than 4 month of attack Have two or more headache attacks over the past 3 month 20 years 70 years Both Patients with mental illness Patients with systemic and background diseases such as diabetes, liver or malignant diseases Pregnant and Lactating women Desire to quit of this study See incidence of complications G43 Migraine Treatment - Drugs Treatment - Drugs Intervention group: Treatment in Group 1 using sodium valproate Intervention group: Treatment in group two using rosuvastatin tablets Migraine headache. Timepoint: Follow up these Patient will be done for 3 months. Method of measurement: The severity of migraine headache is measured by the Visual Analogue Scale (VAS). Ghoum University of Medical Sciences Approved 2018-01-02 Ethics Committee of Qom University of Medical Sciences Qom University of Medical Science and Health service, Saheli Ave, Qom Qom Ghoum Iran (Islamic Republic of)